Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$24.81 - $31.52 $1.06 Million - $1.34 Million
-42,600 Reduced 66.98%
21,000 $589,000
Q3 2022

Nov 14, 2022

BUY
$19.51 - $34.14 $844,783 - $1.48 Million
43,300 Added 213.3%
63,600 $1.8 Million
Q2 2022

Aug 15, 2022

SELL
$17.06 - $31.42 $701,166 - $1.29 Million
-41,100 Reduced 66.94%
20,300 $451,000
Q2 2021

Aug 16, 2021

BUY
$52.06 - $61.27 $3.2 Million - $3.76 Million
61,400 New
61,400 $3.38 Million
Q3 2020

Nov 13, 2020

SELL
$33.87 - $55.93 $1.52 Million - $2.52 Million
-45,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$34.45 - $53.48 $1.55 Million - $2.41 Million
45,000 New
45,000 $2.41 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $1.89B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.